Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today that Eric Furfine, Ph.D., Eleven’s Chief Scientific Officer, is scheduled to present at the Targeting Ocular Disorders Conference being held September 26-27, 2013 in Boston, MA. The presentation, entitled ‘Inhibition of Cytokine Signaling to Treat Ocular Diseases,’ will take place on Friday, September 27, 2013 at 2:20 p.m. ET during the Looking to the Future session which Dr. Furfine will also chair.
Help employers find you! Check out all the jobs and post your resume.
